Growing evidence supports the use of virtual controls in toxicology, but their broader adoption will depend on rigorous data curation, pathology expertise, and robust validation.
A machine learning-based screen identified SRSF1 as a potential target for reversing several hallmarks of aging without erasing cell identity, with further testing revealing benefits in aged mice.
Learn how developmental and reproductive toxicology study selection supports regulatory decision-making and generates meaningful nonclinical safety data.
KCL-286 repaired neuronal DNA damage and reduced neuroinflammation in mice, with prior Phase 1 safety data potentially accelerating its path to Alzheimer's trials.
Despite growing regulatory acceptance, widespread adoption of NAMs depends on workflow integration, reproducibility, and perceived risk in industry decision-making.
New findings suggest that the location of mRNA expression in the body plays a critical role in shaping T cell responses, opening the door to more precise and effective mRNA-based treatments.
From molecular developability to functional activity, integrated characterization strategies help inform lead selection and optimization in biologics discovery.